BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12623996)

  • 1. Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells.
    Andresen BT; Linnoila JJ; Jackson EK; Romero GG
    Hypertension; 2003 Mar; 41(3 Pt 2):781-6. PubMed ID: 12623996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor.
    Bokemeyer D; Schmitz U; Kramer HJ
    Kidney Int; 2000 Aug; 58(2):549-58. PubMed ID: 10916078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D.
    Li F; Malik KU
    J Pharmacol Exp Ther; 2005 Mar; 312(3):1043-54. PubMed ID: 15525798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats.
    Touyz RM; Wu XH; He G; Salomon S; Schiffrin EL
    Hypertension; 2002 Feb; 39(2 Pt 2):479-85. PubMed ID: 11882594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR.
    Andresen BT; Jackson EK; Romero GG
    Hypertension; 2001 Feb; 37(2 Pt 2):635-9. PubMed ID: 11230348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of angiotensin II on extracellular signal-regulated protein kinases signaling pathway in cultured vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats].
    Zhu JH; Liu Z; Huang ZY; Li S
    Sheng Li Xue Bao; 2005 Oct; 57(5):587-92. PubMed ID: 16220196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells.
    Uchiyama-Tanaka Y; Matsubara H; Nozawa Y; Murasawa S; Mori Y; Kosaki A; Maruyama K; Masaki H; Shibasaki Y; Fujiyama S; Nose A; Iba O; Hasagawa T; Tateishi E; Higashiyama S; Iwasaka T
    Kidney Int; 2001 Dec; 60(6):2153-63. PubMed ID: 11737589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes.
    Flannery PJ; Spurney RF
    Nephron Exp Nephrol; 2006; 103(3):e109-18. PubMed ID: 16554661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway.
    Li X; Lee JW; Graves LM; Earp HS
    EMBO J; 1998 May; 17(9):2574-83. PubMed ID: 9564040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical stretch potentiates angiotensin II-induced proliferation in spontaneously hypertensive rat vascular smooth muscle cells.
    Liu G; Hitomi H; Hosomi N; Lei B; Pelisch N; Nakano D; Kiyomoto H; Ma H; Nishiyama A
    Hypertens Res; 2010 Dec; 33(12):1250-7. PubMed ID: 20927110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
    Sandoval YH; Li Y; Anand-Srivastava MB
    Cell Signal; 2011 Nov; 23(11):1716-26. PubMed ID: 21712088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mu opioid transactivation and down-regulation of the epidermal growth factor receptor in astrocytes: implications for mitogen-activated protein kinase signaling.
    Belcheva MM; Tan Y; Heaton VM; Clark AL; Coscia CJ
    Mol Pharmacol; 2003 Dec; 64(6):1391-401. PubMed ID: 14645669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
    Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
    Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: role of receptor tyrosine kinase transactivation.
    Touyz RM; Cruzado M; Tabet F; Yao G; Salomon S; Schiffrin EL
    Can J Physiol Pharmacol; 2003 Feb; 81(2):159-67. PubMed ID: 12710530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independence of angiotensin II-induced MAP kinase activation from angiotensin type 1 receptor internalization in clone 9 hepatocytes.
    Shah BH; Alberto Olivares-Reyes J; Yesilkaya A; Catt KJ
    Mol Endocrinol; 2002 Mar; 16(3):610-20. PubMed ID: 11875120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor.
    Frank GD; Eguchi S; Inagami T; Motley ED
    Biochem Biophys Res Commun; 2001 Feb; 280(4):1116-9. PubMed ID: 11162642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
    J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.
    Nguyen HT; Adam RM; Bride SH; Park JM; Peters CA; Freeman MR
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1155-67. PubMed ID: 11003596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II-dependent growth of vascular smooth muscle cells requires transactivation of the epidermal growth factor receptor via a cytosolic phospholipase A(2)-mediated release of arachidonic acid.
    Freeman EJ; Sheakley ML; Clements RJ
    Arch Biochem Biophys; 2010 Jun; 498(1):50-6. PubMed ID: 20388488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKC-zeta is required for angiotensin II-induced activation of ERK and synthesis of C-FOS in MCF-7 cells.
    Muscella A; Greco S; Elia MG; Storelli C; Marsigliante S
    J Cell Physiol; 2003 Oct; 197(1):61-8. PubMed ID: 12942541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.